European Spending on Electronic Health Records Through 2012 (Databook)
| Publication Date | November 2007 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 42 |
| ISBN Number | not applicable |
| Product Code | DAT08356 |
Summary
Introduction
Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions.
Scope
- Identifies potential growth areas for the EHR market
- Quantifies spending on EHRs by application
- Segments EHR spending by geography and technology
Highlights
The uptake of EHRs will increase rapidly in the next five years and will continue to increase after 2012.
Datamonitor expects Software as a Service to become more prevalent in the EHR market.
Reasons to Purchase
- Understand the current and future direction of EHR investment
- Compare opportunities across countries and market segments
Content
- Overview
- Catalyst
- Summary
- Methodology
- Introduction
- European Spending On Ehrs Through 2012
- Spending On Ehrs In The Uk Through 2012
- Ambulatory Spending On Ehrs In The Uk Through 2012
- Hospital Spending On Ehrs In The Uk Through 2012
- Spending On Ehrs In Germany Through 2012
- Ambulatory Spending On Ehrs In Germany Through 2012
- Hospital Spending On Ehrs In Germany Through 2012
- Spending On Ehrs In France Through 2012
- Ambulatory Spending On Ehrs In France Through 2012
- Hospital Spending On Ehrs In France Through 2012
- Spending On Ehrs In Italy Through 2012
- Ambulatory Spending On Ehrs In Italy Through 2012
- Hospital Spending On Ehrs In Italy Through 2012
- Spending On Ehrs In Benelux Through 2012
- Ambulatory Spending On Ehrs In Benelux Through 2012
- Hospital Spending On Ehrs In Benelux Through 2012
- Spending On Ehrs In The Nordics Through 2012
- Ambulatory Spending On Ehrs In The Nordics Through 2012
- Hospital Spending On Ehrs In The Nordics Through 2012
- Spending On Ehrs In Neu 10 Through 2012
- Ambulatory Spending On Ehrs In Neu 10 Through 2012
- Hospital Spending On Ehrs In Neu 10 Through 2012
- Spending On Ehrs In The Rowe Through 2012
- Ambulatory Spending On Ehrs In The Rowe Through 2012
- Hospital Spending On Ehrs In The Rowe Through 2012
- Spending On Ehrs In Spain Through 2012
- Ambulatory Spending On Ehrs In Spain Through 2012
- Hospital Spending On Ehrs In Spain Through 2012
- Spending On Ehrs In Switzerland Through 2012
- Ambulatory Spending On Ehrs In Switzerland Through 2012
- Hospital Spending On Ehrs In Switzerland Through 2012
- Appendix
- Definitions
- Further Reading
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
- Figure 1: European Spending On Ehrs Through 2012 (Million Us$)
- Figure 2: Spending On Ehrs In The Uk Through 2012 (Million Us$)
- Figure 3: Ambulatory Spending On Ehrs In The Uk Through 2012 (Million Us$)
- Figure 4: Hospital Spending On Ehrs In The Uk Through 2012 (Million Us$)
- Figure 5: Spending On Ehrs In Germany Through 2012 (Million Us$)
- Figure 6: Ambulatory Spending On Ehrs In Germany Through 2012 (Million Us$)
- Figure 7: Hospital Spending On Ehrs In Germany Through 2012 (Million Us$)
- Figure 8: Spending On Ehrs In France Through 2012 (Million Us$)
- Figure 9: Ambulatory Spending On Ehrs In France Through 2012 (Million Us$)
- Figure 10: Hospital Spending On Ehrs In France Through 2012 (Million Us$)
- Figure 11: Spending On Ehrs In Italy Through 2012 (Million Us$)
- Figure 12: Ambulatory Spending On Ehrs In Italy Through 2012 (Million Us$)
- Figure 13: Hospital Spending On Ehrs In Italy Through 2012 (Million Us$)
- Figure 14: Spending On Ehrs In Benelux Through 2012 (Million Us$)
- Figure 15: Ambulatory Spending On Ehrs In Benelux Through 2012 (Million Us$)
- Figure 16: Hospital Spending On Ehrs In Benelux Through 2012 (Million Us$)
- Figure 17: Spending On Ehrs In The Nordics Through 2012 (Million Us$)
- Figure 18: Ambulatory Spending On Ehrs In The Nordics Through 2012 (Million Us$)
- Figure 19: Hospital Spending On Ehrs In The Nordics Through 2012 (Million Us$)
- Figure 20: Spending On Ehrs In Neu 10 Through 2012 (Million Us$)
- Figure 21: Ambulatory Spending On Ehrs In Neu 10 Through 2012 (Million Us$)
- Figure 22: Hospital Spending On Ehrs In Neu 10 Through 2012 (Million Us$)
- Figure 23: Spending On Ehrs In The Rowe Through 2012 (Million Us$)
- Figure 24: Ambulatory Spending On Ehrs In The Rowe Through 2012 (Million Us$)
- Figure 25: Hospital Spending On Ehrs In The Rowe Through 2012 (Million Us$)
- Figure 2: Spending On Ehrs In Spain Through 2012 (Million Us$)
- Figure 27: Ambulatory Spending On Ehrs In Spain Through 2012 (Million Us$)
- Figure 28: Hospital Spending On Ehrs In Spain Through 2012 (Million Us$)
- Figure 29: Spending On Ehrs In Switzerland Through 2012 (Million Us$)
- Figure 30: Ambulatory Spending On Ehrs In Switzerland Through 2012 (Million Us$)
- Figure 31: Hospital Spending On Ehrs In Switzerland Through 2012 (Million Us$)
- Table 1: European Spending On Ehrs Through 2012 (Million Us$)
- Table 2: Spending On Ehrs In The Uk Through 2012 (Million Us$)
- Table 3: Ambulatory Spending On Ehrs In The Uk Through 2012 (Million Us$)
- Table 4: Hospital Spending On Ehrs In The Uk Through 2012 (Million Us$)
- Table 5: Spending On Ehrs In Germany Through 2012 (Million Us$)
- Table 6: Ambulatory Spending On Ehrs In Germany Through 2012 (Million Us$)
- Table 7: Hospital Spending On Ehrs In Germany Through 2012 (Million Us$)
- Table 8: Spending On Ehrs In France Through 2012 (Million Us$)
- Table 9: Ambulatory Spending On Ehrs In France Through 2012 (Million Us$)
- Table 10: Hospital Spending On Ehrs In France Through 2012 (Million Us$)
- Table 11: Spending On Ehrs In Italy Through 2012 (Million Us$)
- Table 12: Ambulatory Spending On Ehrs In Italy Through 2012 (Million Us$)
- Table 13: Hospital Spending On Ehrs In Italy Through 2012 (Million Us$)
- Table 14: Spending On Ehrs In Benelux Through 2012 (Million Us$)
- Table 15: Ambulatory Spending On Ehrs In Benelux Through 2012 (Million Us$)
- Table 16: Hospital Spending On Ehrs In Benelux Through 2012 (Million Us$)
- Table 17: Spending On Ehrs In The Nordics Through 2012 (Million Us$)
- Table 18: Ambulatory Spending On Ehrs In The Nordics Through 2012 (Million Us$)
- Table 19: Hospital Spending On Ehrs In The Nordics Through 2012 (Million Us$)
- Table 20: Spending On Ehrs In Neu 10 Through 2012 (Million Us$)
- Table 21: Ambulatory Spending On Ehrs In Neu 10 Through 2012 (Million Us$)
- Table 22: Hospital Spending On Ehrs In Neu 10 Through 2012 (Million Us$)
- Table 23: Spending On Ehrs In The Rowe Through 2012 (Million Us$)
- Table 24: Ambulatory Spending On Ehrs In The Rowe Through 2012 (Million Us$)
- Table 25: Hospital Spending On Ehrs In The Rowe Through 2012 (Million Us$)
- Table 26: Spending On Ehrs In Spain Through 2012 (Million Us$)
- Table 27: Ambulatory Spending On Ehrs In Spain Through 2012 (Million Us$)
- Table 28: Hospital Spending On Ehrs In Spain Through 2012 (Million Us$)
- Table 29: Spending On Ehrs In Switzerland Through 2012 (Million Us$)
- Table 30: Ambulatory Spending On Ehrs In Switzerland Through 2012 (Million Us$)
- Table 31: Hospital Spending On Ehrs In Switzerland Through 2012 (Million Us$)
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
PRINT/CD-ROM:Despatched within 1 to 2 working days.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















